the role of rna modifications in mds and aml
Published 1 year ago • 41 plays • Length 0:55Download video MP4
Download video MP3
Similar videos
-
1:51
factors driving the transformation of chip to mds
-
3:10
the role of ngs in mds diagnosis
-
1:16
state of the art: mds
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
2:03
molecular pathogenesis and immune dysregulation in mds
-
1:34
sequencing of agents in lr-mds
-
48:24
rfa analyst about prime minister hun manet 08 8 2024
-
7:54
patient/caregiver stories - living with mds
-
4:28
understanding myelodysplastic syndromes (mds)
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
4:04
the impact of regulatory rna molecules
-
1:03
the growing importance of single-cell rna sequencing in hematology
-
1:39
the mechanism of action of navtemadlin and its role in mf
-
1:13
expanding treatment options for aml to patients with mds
-
9:25
improving mds management: new targets, drug combinations, and personalized and cellular therapies
-
2:04
state-of-the-art treatment for hr-mds
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:06
the current state of the art in hr-mds and the need to improve treatment approaches